258 related articles for article (PubMed ID: 18551200)
1. Effect of fluticasone 250 microg/salmeterol 50 microg and montelukast on exhaled nitric oxide in asthmatic patients.
Gelb AF; Taylor CF; Shinar CM; Gutierrez CA; Zamel N
Can Respir J; 2008; 15(4):193-8. PubMed ID: 18551200
[TBL] [Abstract][Full Text] [Related]
2. Role of add-on zileuton on total exhaled, large airway, and small airway/alveolar nitric oxide in moderate-severe persistent adult asthmatics on fluticasone 250 microg/Salmeterol 50 microg.
Gelb AF; Taylor CF; Simmons M; Shinar C
Pulm Pharmacol Ther; 2009 Dec; 22(6):516-21. PubMed ID: 19467341
[TBL] [Abstract][Full Text] [Related]
3. Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children.
Ghiro L; Zanconato S; Rampon O; Piovan V; Pasquale MF; Baraldi E
Eur Respir J; 2002 Sep; 20(3):630-4. PubMed ID: 12358339
[TBL] [Abstract][Full Text] [Related]
4. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma.
Fritscher LG; Rodrigues MT; Zamel N; Chapman KR
Respir Med; 2009 Feb; 103(2):296-300. PubMed ID: 18805684
[TBL] [Abstract][Full Text] [Related]
5. Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthma.
Akamatsu T; Shirai T; Kato M; Yasui H; Hashimoto D; Fujisawa T; Tsuchiya T; Inui N; Suda T; Chida K
Pulm Pharmacol Ther; 2014 Feb; 27(1):52-6. PubMed ID: 23583566
[TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
O'Connor RD; Nelson H; Borker R; Emmett A; Jhingran P; Rickard K; Dorinsky P
Pharmacoeconomics; 2004; 22(12):815-25. PubMed ID: 15294013
[TBL] [Abstract][Full Text] [Related]
7. Comparison of add-on therapy to inhaled fluticasone propionate in children with asthma: residual volume and exhaled nitric oxide as outcome measures.
Verini M; Peroni DG; Piacentini GL; Nicodemo A; Rossi N; Bodini A; Chiarelli F; Boner AL
Allergy Asthma Proc; 2007; 28(6):691-4. PubMed ID: 18201433
[TBL] [Abstract][Full Text] [Related]
8. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
[TBL] [Abstract][Full Text] [Related]
9. Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.
O'Connor RD; Stanford R; Crim C; Yancey SW; Edwards L; Rickard KA; Dorinsky P
Ann Allergy Asthma Immunol; 2004 Dec; 93(6):581-8. PubMed ID: 15609769
[TBL] [Abstract][Full Text] [Related]
10. Predictors of asthma control and lung function responsiveness to step 3 therapy in children with uncontrolled asthma.
Rabinovitch N; Mauger DT; Reisdorph N; Covar R; Malka J; Lemanske RF; Morgan WJ; Guilbert TW; Zeiger RS; Bacharier LB; Szefler SJ
J Allergy Clin Immunol; 2014 Feb; 133(2):350-6. PubMed ID: 24084071
[TBL] [Abstract][Full Text] [Related]
11. The effect of low-dose inhaled fluticasone propionate on exhaled nitric oxide in asthmatic patients and comparison with oral zafirlukast.
Lanz MJ; Eisenlohr C; Llabre MM; Toledo Y; Lanz MA
Ann Allergy Asthma Immunol; 2001 Oct; 87(4):283-8. PubMed ID: 11686419
[TBL] [Abstract][Full Text] [Related]
12. Comparisons of the complementary effect on exhaled nitric oxide of salmeterol vs montelukast in asthmatic children taking regular inhaled budesonide.
Buchvald F; Bisgaard H
Ann Allergy Asthma Immunol; 2003 Sep; 91(3):309-13. PubMed ID: 14533665
[TBL] [Abstract][Full Text] [Related]
13. Effects of low dose fluticasone/salmeterol combination on surrogate inflammatory markers in moderate persistent asthma.
Currie GP; Syme-Grant NJ; McFarlane LC; Carey FA; Lipworth BJ
Allergy; 2003 Jul; 58(7):602-7. PubMed ID: 12823118
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids.
Wilson AM; Dempsey OJ; Sims EJ; Lipworth BJ
Chest; 2001 Apr; 119(4):1021-6. PubMed ID: 11296164
[TBL] [Abstract][Full Text] [Related]
15. Randomized comparison of strategies for reducing treatment in mild persistent asthma.
; Peters SP; Anthonisen N; Castro M; Holbrook JT; Irvin CG; Smith LJ; Wise RA
N Engl J Med; 2007 May; 356(20):2027-39. PubMed ID: 17507702
[TBL] [Abstract][Full Text] [Related]
16. [A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination].
Grosclaude M; Cerruti JL; Delannay B; Hérent M; Spilthooren F; Desfougères JL
Eur Ann Allergy Clin Immunol; 2003 Nov; 35(9):356-62. PubMed ID: 14716965
[TBL] [Abstract][Full Text] [Related]
17. Additive bronchoprotective and bronchodilator effects with single doses of salmeterol and montelukast in asthmatic patients receiving inhaled corticosteroids.
Dempsey OJ; Wilson AM; Sims EJ; Mistry C; Lipworth BJ
Chest; 2000 Apr; 117(4):950-3. PubMed ID: 10767223
[TBL] [Abstract][Full Text] [Related]
18. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial.
Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening AP; Haahtela T; Holgate ST; Picado C; Menten J; Dass SB; Leff JA; Polos PG
BMJ; 2003 Oct; 327(7420):891. PubMed ID: 14563743
[TBL] [Abstract][Full Text] [Related]
19. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
[TBL] [Abstract][Full Text] [Related]
20. Airway mechanics after withdrawal of a leukotriene receptor antagonist in children with mild persistent asthma: Double-blind, randomized, cross-over study.
Kim JH; Lee S; Shin YH; Ha EK; Lee SW; Kim MA; Yoon JW; Baek HS; Choi SH; Han MY
Pediatr Pulmonol; 2020 Dec; 55(12):3279-3286. PubMed ID: 32965787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
